Fish bones may fortify Women's bones: new study
NCT ID NCT05066477
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a supplement made from salmon bone powder (CalGo) could help prevent bone loss in perimenopausal women with low bone density. Eighty women aged 50 and older took either the supplement or a placebo for up to 24 months. Researchers measured changes in bone density at the hip, spine, and forearm to see if the supplement slowed bone thinning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
salmon bone meal (CalGo) with vitamin D3
What this could lead to
If it works, this could provide a natural dietary supplement to help maintain bone density in women at risk for osteoporosis.
What could go wrong
This is a small, completed trial with 80 participants. The supplement may not significantly slow bone loss, and results may not apply to all women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hofseth Biocare ASA
Ålesund, Møre og Romsdal, 6005, Norway
-
Kristiansund Hospital
Kristiansund, Møre og Romsdal, 6508, Norway
-
Lovisenberg Diakonale Sykehus
Oslo, 0456, Norway